Leerink upgrades Abbott to Outperform, sees MedTech poised to outperform in 2027
FROM THE WIRE · SEEKINGALPHA.COM
Abbott Laboratories (ABT) stock gains as Leerink Partners to Outperform from Market Perform, citing significant gains ahead for the MedTech sector. Read more here.
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bullishA broker upgrade of a healthcare giant can move the stock and sentiment across the MedTech sector.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Leerink Partners upgraded Abbott to Outperform from Market Perform.
- 02The broker cites significant expected gains for the MedTech sector.
- 03The Abbott stock is rising on the news.
NEWS IMPACT AND MARKET REACTIONChange from the reference price
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets